These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8987240)

  • 1. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
    Wiholm BE; Emanuelsson S
    Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced blood dyscrasias in Sweden.
    Böttiger LE; Westerholm B
    Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia.
    Böttiger LE; Böttiger B
    Acta Med Scand; 1981; 210(6):475-9. PubMed ID: 7331894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
    Böttiger LE; Furhoff AK; Holmberg L
    Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the aetiology of agranulocytosis and aplastic anaemia.
    Kaufman DW; Kelly JP; Jurgelon JM; Anderson T; Issaragrisil S; Wiholm BE; Young NS; Leaverton P; Levy M; Shapiro S
    Eur J Haematol Suppl; 1996; 60():23-30. PubMed ID: 8987237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematologic reactions to carbonic anhydrase inhibitors.
    Fraunfelder FT; Meyer SM; Bagby GC; Dreis MW
    Am J Ophthalmol; 1985 Jul; 100(1):79-81. PubMed ID: 4014383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
    Levy M; Kelly JP; Kaufman DW; Shapiro S
    Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
    Rawson NS; Harding SR; Malcolm E; Lueck L
    J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system.
    Keisu M; Wiholm BE; Palmblad J
    J Intern Med; 1990 Oct; 228(4):353-60. PubMed ID: 2266345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoprofen-induced aplastic anemia in active connective tissue disease detected by drug-specific lymphocyte transformation.
    Saal JG; Daniel PT; Berg PA
    Klin Wochenschr; 1986 May; 64(10):481-5. PubMed ID: 3723995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases.
    Polak BC; Wesseling H; Schut D; Herxheimer A; Meyler L
    Acta Med Scand; 1972 Nov; 192(5):409-14. PubMed ID: 5083381
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
    Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced blood disorders.
    Danielson DA; Douglas SW; Herzog P; Jick H; Porter JB
    JAMA; 1984 Dec; 252(23):3257-60. PubMed ID: 6151006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced blood dyscrasia in Kinki district].
    Nakayama S; Yabe H
    Rinsho Ketsueki; 1991 Jul; 32(7):718-20. PubMed ID: 1920833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood dyscrasias and mianserin.
    Adams PC; Robinson A; Reid MM; Vishu MC; Livingston M
    Postgrad Med J; 1983 Jan; 59(687):31-3. PubMed ID: 6866871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.
    Patton WN; Duffull SB
    Drug Saf; 1994 Dec; 11(6):445-62. PubMed ID: 7727054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative incidence of agranulocytosis and aplastic anemia.
    Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS
    Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
    Kelly JP; Kaufman DW; Shapiro S
    Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of clinical blood dyscrasia in a cohort of antibiotic users.
    Huerta C; García Rodríguez LA
    Pharmacotherapy; 2002 May; 22(5):630-6. PubMed ID: 12013362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.